Literature DB >> 22577157

IKDCs or B220+ NK cells are pre-mNK cells.

Laurence Zitvogel1, Franck Housseau.   

Abstract

Entities:  

Year:  2012        PMID: 22577157     DOI: 10.1182/blood-2012-03-415026

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

Review 1.  Immunological off-target effects of imatinib.

Authors:  Laurence Zitvogel; Sylvie Rusakiewicz; Bertrand Routy; Maha Ayyoub; Guido Kroemer
Journal:  Nat Rev Clin Oncol       Date:  2016-03-31       Impact factor: 66.675

2.  Jak1 Integrates Cytokine Sensing to Regulate Hematopoietic Stem Cell Function and Stress Hematopoiesis.

Authors:  Maria Kleppe; Matthew H Spitzer; Sheng Li; Corinne E Hill; Lauren Dong; Efthymia Papalexi; Sofie De Groote; Robert L Bowman; Matthew Keller; Priya Koppikar; Franck T Rapaport; Julie Teruya-Feldstein; Jorge Gandara; Christopher E Mason; Garry P Nolan; Ross L Levine
Journal:  Cell Stem Cell       Date:  2017-09-28       Impact factor: 24.633

Review 3.  Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy.

Authors:  Neale Hanke; Darya Alizadeh; Emmanuel Katsanis; Nicolas Larmonier
Journal:  Crit Rev Immunol       Date:  2013       Impact factor: 2.214

4.  A role for pre-mNK cells in tumor progression.

Authors:  Carolyn Rosinsky; Paul Andrew Antony
Journal:  J Immunother Cancer       Date:  2016-03-15       Impact factor: 13.751

5.  IL-15 Generates IFN-γ-producing Cells Reciprocally Expressing Lymphoid-Myeloid Markers during Dendritic Cell Differentiation.

Authors:  Kee Woong Kwon; So Jeong Kim; Hongmin Kim; Woo Sik Kim; Soon Myung Kang; Eunsol Choi; Sang-Jun Ha; Joo-Heon Yoon; Sung Jae Shin
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

6.  Natural killer cells limit the clearance of senescent lung adenocarcinoma cells.

Authors:  Kate L Stokes; Virna Cortez-Retamozo; Jonuelle Acosta; Brian Lauderback; Camila Robles-Oteiza; Michelle Cicchini; Mikael J Pittet; David M Feldser
Journal:  Oncogenesis       Date:  2019-04-01       Impact factor: 7.485

7.  How imiquimod licenses plasmacytoid dendritic cells to kill tumors.

Authors:  Martin Holcmann; Barbara Drobits; Maria Sibilia
Journal:  Oncoimmunology       Date:  2012-12-01       Impact factor: 8.110

Review 8.  Revisiting the Prominent Anti-Tumoral Potential of Pre-mNK Cells.

Authors:  Fanny Guimont-Desrochers; Sylvie Lesage
Journal:  Front Immunol       Date:  2013-12-11       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.